Table 3 Safety of TUNA. Non-comparative studies
Adverse effect | No. events | Percentage of total patients |
|---|---|---|
Hematuria: | Â | Â |
- Mild | 337 | 28% |
- Moderate | 85 | 7% |
- Transitory unspecified severity | 25 | 2% |
- Severe | 16 | 1% |
Transitory urinary retention | 279 | 23% |
Dysuria | 167 | 14% |
Irritative symptoms | 117 | 10% |
Urinary tract infection | 43 | 4% |
Pain during procedure | Â | Â |
Moderate | 11 | 0.9% |
Intense | 4 | 0.3% |
Postoperative perineal pain | 13 | 1% |
Epidydimo-orchitis | 11 | 0.9% |
Mild-moderate burning sensation | 10 | 0.8% |
High fever | 8 | 0.7% |
Treatment halted due to intolerance to procedure | 6 | 0.5% |
Urethral stenosis | 6 | 0.5% |
Erectile dysfunction | 4 | 0.3% |
Hemospermia | 4 | 0.3% |
Retrograde ejaculation | 3 | 0.2% |
Loss of ejaculation | 1 | 0.08% |
Prostatism | 2 | 0.2% |
Complex bladder dysfunction | 1 | 0.08% |
Damage in the mucosa | 1 | 0.08% |
Deep vein thrombosis | 1 | 0.08% |